TEL AVIV, Israel & MELBOURNE, Australia–(BUSINESS WIRE)–Azura Ophthalmics Ltd., a clinical-stage biopharmaceutical company developing a new therapeutic class of Ophthalmic Keratolytics for ocular surface diseases, today announced positive topline eff…
Category: Business
VISIE Inc., a Medtech Computer Vision and Spatial Computing Company, Joins NVIDIA Inception to Up Its Computing Power
AUSTIN, Texas–(BUSINESS WIRE)–VISIE Inc., formerly Advanced Scanners, today announced it has joined NVIDIA Inception, a program that empowers early-stage companies revolutionizing industries with technological advancements. VISIE is a medtech growth …
KeraLink International Launches the Great Cornea Challenge and a Cornea Technology Accelerator
BALTIMORE–(BUSINESS WIRE)–KeraLink International (KLI) today announced the launch of the Great Cornea Challenge and the Cornea Technology Accelerator. These bold initiatives are designed to attract and support innovators and entrepreneurs to help in …
Cincinnati Eye Institute, an EyeCare Partners Practice, Opens New CEI Retina Clinic at The Landings in Blue Ash
CINCINNATI–(BUSINESS WIRE)–EyeCare Partners (ECP), the nation’s leading provider of clinically integrated eye care, today announced the grand opening of its Cincinnati Eye Institute (CEI) Retina Clinic at The Landings in Blue Ash, furthering its comm…
Gyros Protein Technologies and Biotage partner to advance peptide purification efficiency with new automated solution
UPPSALA, Sweden–(BUSINESS WIRE)–Gyros Protein Technologies AB, a leading provider of peptide synthesizers and reagents and a pioneer in automated nanoliter-scale immunoassays, and Biotage, a global life sciences company, providing high-quality purifi…
NovaBay Pharmaceuticals Partners with Woo University to Educate Eyecare Professionals on the Use of Amniotic Membranes
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) announces its partnership with Woo University to support the education of eyecare professionals on the use of amniotic membranes. A free webinar is being held Thurs…
iHealthScreen Inc. Announces UK Medicines and Healthcare Products Regulatory Agency (MHRA) Certification and registration for iPredict™ – Automated AI System for Early Diagnosis of DR, AMD, and Glaucoma
NEW YORK–(BUSINESS WIRE)– #AI–Automated AI System for Early Diagnosis of Diabetic Retinopathy (DR), Age-Related Macular degeneration (AMD), and Glaucoma, and help prevent blindness
Yolanda Becker, MD Joins LifeGift as Vice President and Chief Medical Officer
HOUSTON–(BUSINESS WIRE)–LifeGift announces Yolanda Becker, MD, FACS, FAST, has joined the team as vice president and chief medical officer.
Horus Pharma Is Strengthening Its International Expansion in Support of Its Growth
NICE, France–(BUSINESS WIRE)–Horus Pharma, an independent French company leading player in ophthalmology, strengthens its international presence with the signature of eight distribution agreements – covering Romania, Portugal, Croatia, Turkey, Algeri…
Eye Center of North Florida Announces Winner of Their 13th Annual LASIK Hero Campaign
PANAMA CITY, Fla.–(BUSINESS WIRE)–Eye Center of North Florida announces Cody Hill as the winner of their 13th annual LASIK Hero campaign.
Lilian Zhou Appointed to STAAR Surgical Board of Directors
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (ICL) for myopia, astigmatism and presbyopia, today announced the appointment …
Harrow Completes Transfer of the TRIESENCE® New Drug Application
NASHVILLE, Tenn.–(BUSINESS WIRE)—- $HROW–Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced the completion of the transfer to Harrow of the New Drug Application (NDA) for TRIESENCE® (triamcinolone acetonide inject…
Europe Contact Lenses Market Insights Report 2023: A $2.23 Billion Market in 2022 – Forecasts to 2028 with Profiles of Prominent Vendors – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Europe Contact Lenses Market – Focused Insights 2023-2028” report has been added to ResearchAndMarkets.com’s offering. European contact lenses market was valued at $2.23 billion in 2022 and is expected to grow at a CAGR of…
Berlin Cures advances fight against Long COVID on a pan-European level
BERLIN–(BUSINESS WIRE)–Berlin Cures, a biotechnology company specialized in neutralizing functional autoantibodies (fAABs), is expanding its Phase II clinical trial into a pan-European, multi-center collaboration in the fight against Long COVID. A to…
Delta Dental of Tennessee Launches Annual Holiday Campaign With $75,000 Pledge to Children's Hospitals Across Tennessee
NASHVILLE, Tenn.–(BUSINESS WIRE)–Delta Dental of Tennessee launched its annual holiday campaign, pledging a collective $75,000 in donations to children’s hospitals across the state.
Prevent Blindness Georgia Raises $320,000 To Expand Their Vision Saving Initiatives For Underserved Youth and Adults At 7TH Annual Night for Sight Gala
ATLANTA–(BUSINESS WIRE)–Prevent Blindness Georgia (PBGA), the state’s leading voluntary eye health organization dedicated to saving sight and restoring vision, is proud to share that it has successfully raised $320,000 to support its vision saving in…
BTIG to Host 3rd Annual Ophthalmology Day on November 27, 2023
NEW YORK–(BUSINESS WIRE)–BTIG announced today that its 3rd Annual Ophthalmology Day will take place on Monday, November 27, 2023. The virtual, one-day event will include thematic panel discussions, one-on-one meetings and company presentations. The e…
Harrow to Present at Two Investor Conferences in November
NASHVILLE, Tenn.–(BUSINESS WIRE)—- $HROW–Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced that Mark L. Baum, Chief Executive Officer, and Andrew Boll, Chief Financial Officer, will participate in the following t…
STAAR Surgical to Present at Stephens Annual Investment Conference (NASH2023)
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (ICL) for myopia, astigmatism and presbyopia, today announced that management …
LENZ Therapeutics and Graphite Bio Announce Merger Agreement
SAN DIEGO & SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–LENZ Therapeutics, a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies to improve vision, and Graphite Bio, Inc. (NASDAQ: GRPH) today announced …